Legislative Proposal, Bill or Resolution, Policies or Program
Changes to NAFTA relevant for life sciences sector
Policies or Program
Canada's engagement in international trade agreements in particular the Canadian European Trade Agreement (CETA) and Trans Pacific Partnership (TPP) and any other agreements as it relates to intellectual property considerations and other aspects which affect the local business environment for J&J companies.
Canada's partnerships on global health with Johnson & Johnson on maternal and child health as well as First Nations
Chemicals Management Plan as related to the regulation of chemical substances, particularly as effecting ingredients used in therapeutic products.
Encourage the creation of Canada's leadership on programs and policies on mental health
Engagement on the government's consultation on the Innovation Policy
Food and Drug Act: Delays in new product approvals and changes to existing products
Policies or Program, Regulation
Evolution of role and mandate of the drug pricing regime in Canada
Health Canada’s multi-year Regulatory Modernization initiative to modernize the Food and Drugs Act and Regulations, specifically with respect to the approval, regulation and life-cycle management of therapeutic products
Regulation
Environmental Assessment Regulations as related to the regulation of chemical substances, particularly as effecting ingredients used in therapeutic products.